Optical coherence tomography angiography in treated type 2 neovascularization undergoing monthly anti-VEGF treatment

Acta Ophthalmol. 2017 Aug;95(5):e425-e426. doi: 10.1111/aos.13180. Epub 2016 Aug 6.

Authors

Mariacristina Parravano¹, Lea Querques², Fabio Scarinci¹, Paola Giorno¹, Daniele De Geronimo¹, Roberto Gattegna¹, Monica Varano¹, Francesco Bandello², Giuseppe Querques²

Affiliations

¹ G. B. Bietti Foundation-IRCCS, Rome, Italy.
² Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele Hospital, Milan, Italy.

PMID: 27496070
DOI: 10.1111/aos.13180

No abstract available

Publication types

Letter

MeSH terms

Aged
Angiogenesis Inhibitors / administration & dosage
Bevacizumab / administration & dosage*
Choroid / blood supply
Choroid / pathology*
Choroidal Neovascularization / diagnosis*
Choroidal Neovascularization / drug therapy
Fluorescein Angiography / methods
Fundus Oculi
Humans
Intravitreal Injections
Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
Reproducibility of Results
Tomography, Optical Coherence / methods*

Substances

Angiogenesis Inhibitors
Bevacizumab
Receptors, Vascular Endothelial Growth Factor